- New Approaches to the Diagnosis and Treatment of Postmenopausal Osteoporosis
-
Kim B
- KMID: 1511947
- J Korean Soc Endocrinol.
- 2006 Apr;21(2):91-100.
- doi: 10.3803/jkes.2006.21.2.91
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment and Management of Postmenopausal Osteoporosis in China
-
Wu J, Tian Q
- KMID: 2321560
- J Korean Soc Osteoporos.
- 2010 Aug;8(2):123-132.
Considering the aging population, longer life expectancy, and many dramatic changes in people's lifestyles during recent years in China, although the prevalence of postmenopausal osteoporosis in China remains lower than... -
- CITED
-
- Close
- SHARE
-
- Close
- Romosozumab for the treatment of osteoporosis
-
McClung MR
- KMID: 2437854
- Osteoporos Sarcopenia.
- 2018 Mar;4(1):11-15.
- doi: 10.1016/j.afos.2018.03.002
Romosozumab, a specific inhibitor of sclerostin, is a unique approach to therapy for postmenopausal osteoporosis and related disorders. The elucidation of sclerostin deficiency as the molecular defect of syndromes of... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Treatment of Postmenopausal Osteoporosis
-
Yoon SH, Kim JG
- KMID: 2272562
- Korean J Obstet Gynecol.
- 2005 Apr;48(4):844-856.
Osteoporosis is a silent disease which causes a serious morbidity such as fracture. Once osteoporosis risk has been established in postmenopausal women, dietary and lifestyle changes, such as exercise, discontinuing... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of the Knowledge, Health Belief, and Self-Efficacy about Osteoporosis on Calcium Intake Behavior for Postmenopausal Osteoporosis Patients
-
Song HR, So HY
- KMID: 2290769
- J Korean Acad Adult Nurs.
- 2007 Dec;19(5):763-774.
PURPOSE: To identify the predictors of calcium intake behavior and examine the relationships among bone mineral density, osteoporosis knowledge, osteoporosis health belief, osteoporosis self efficacy and calcium intake behavior of... -
- CITED
-
- Close
- SHARE
-
- Close
- New Antiresorptive Therapies for Postmenopausal Osteoporosis
-
Choi HJ
- KMID: 2201015
- J Menopausal Med.
- 2015 Apr;21(1):1-11.
- doi: 10.6118/jmm.2015.21.1.1
Osteoporosis is a systemic skeletal disease whose risk increases with age and it is common among postmenopausal women. Currently, almost all pharmacological agents for osteoporosis target the bone resorption component... -
- CITED
-
- Close
- SHARE
-
- Close
- Denosumab for the treatment of osteoporosis
-
McClung MR
- KMID: 2376998
- Osteoporos Sarcopenia.
- 2017 Mar;3(1):8-17.
- doi: 10.1016/j.afos.2017.01.002
Denosumab, a specific inhibitor of RANK ligand, is a novel therapy for postmenopausal osteoporosis and related disorders. An extensive clinical development program has evaluated the clinical efficacy and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Vitamin K2 in Addition to Risedronate on the Patients with Postmenopausal Osteoporosis
-
Kim SB, Ryoo KH, Lee KW, Kwak H, Yoon K
- KMID: 2178460
- J Korean Acad Rehabil Med.
- 2006 Oct;30(5):491-495.
OBJECTIVE: To assess the effect of vitamin K2 in addition to risedronate on postmenopausal osteoporosis METHOD: We enrolled 21 postmenopausal osteoporosis women (age: 65.2+/-7.8 years). Ten subjects received risedronate (35 mg,... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship among Estradiol, Lipid Profile, Biochemical Markers, and Bone Mineral Density according to Postmenopausal Period
-
Kim GC, Jeong HJ, Jeong SW, Chung HC
- KMID: 2323404
- J Korean Acad Rehabil Med.
- 2000 Apr;24(2):318-325.
OBJECTIVE: To determine whether estradiol (E2), lipid profile, biochemical markers, and bone mineral density (BMD) are related according to postmenopausal period. METHOD: One hundred fifty four women were divided into four... -
- CITED
-
- Close
- SHARE
-
- Close
- The Level of Physical Function and Psychological Well-Being of Postmenopausal Middle-aged Korean Women according to Bone Health Status
-
Kim SL, Cha KS
- KMID: 2293101
- J Korean Acad Community Health Nurs.
- 2006 Mar;17(1):46-55.
OBJECTIVE: This study is to examine the physical function, psychological well-being, and subjective symptom of postmenopausal osteoporotic women. METHODS: Data used for this study was collected from 397 women who had... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of ipriflavone on postmenopausal osteoporosis
-
Weon YJ, Chung YS, Hong KY, Park YK, Kim HS, Lee JH, Lee EJ, Lim SK, Kim KR, Lee HC, Huh KB
- KMID: 1686871
- J Korean Soc Endocrinol.
- 1993 Sep;8(3):259-264.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels
-
Engin-Üstün Y, Çağlayan EK, Göçmen A, Polat MF
- KMID: 2365462
- J Menopausal Med.
- 2016 Aug;22(2):76-79.
- doi: 10.6118/jmm.2016.22.2.76
OBJECTIVES: The objective of this study was to describe the levels of chemerin, irisin and apolipoprotein M (apoM) in women with postmenopausal osteoporosis. METHODS: The study included 88 women with postmenopausal... -
- CITED
-
- Close
- SHARE
-
- Close
- Current and Upcoming Treatments for Osteoporosis
-
Chung YS
- KMID: 2223113
- J Rheum Dis.
- 2012 Feb;19(1):4-10.
- doi: 10.4078/jrd.2012.19.1.4
Osteoporosis is a common senile disease that results in fragility fractures. With an ageing population, the medical and socioeconomic effect of osteoporosis, particularly postmenopausal osteoporosis, will increase further. Currently, good... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of the Combined Therapy with Raloxifene and Low-Dose Intermittent Fluoride for Two Years in Postmenopausal Women with Osteoporosis
-
Chung SM, Kim GC
- KMID: 2324522
- J Korean Acad Rehabil Med.
- 2007 Apr;31(2):207-212.
OBJECTIVE: To compare the effects of raloxifene alone with a combination of raloxifene and fluoride in postmenopausal osteoporosis on bone mineral density, bone turnover and lipid profiles, at 2 year. METHOD:... -
- CITED
-
- Close
- SHARE
-
- Close
- Selective Estrogen Receptor Modulators
-
An KC
- KMID: 2349306
- Asian Spine J.
- 2016 Aug;10(4):787-791.
- doi: 10.4184/asj.2016.10.4.787
Selective estrogen receptor modulators (SERMs) are now being used as a treatment for breast cancer, osteoporosis and postmenopausal symptoms, as these drugs have features that can act as an estrogen... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Parity and Breastfeeding Duration on Bone Density in Postmenopausal Women
-
Lee EN
- KMID: 2449398
- Asian Nurs Res.
- 2019 May;13(2):161-167.
- doi: 10.1016/j.anr.2019.04.002
PURPOSE: This study aimed to identify the effect of parity and breastfeeding duration and the occurrence of lumbar vertebral and femoral neck osteoporosis in Korean postmenopausal women. METHODS: This study analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
- Medial Malleolar Insufficiency Fracture of the Ankle in an Elderly Patient with Osteoporosis
-
Kim GD, Chae SU, Cha MS
- KMID: 2286305
- J Bone Metab.
- 2013 Nov;20(2):119-122.
- doi: 10.11005/jbm.2013.20.2.119
Insufficiency fracture is a type of stress fracture, which is the result of normal stresses on abnormal bone. Postmenopausal osteoporosis is the most common cause of insufficiency fractures. An early... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Childbirth Age on Bone Mineral Density in Postmenopausal Women
-
We JS, Han K, Kwon HS, Kil K
- KMID: 2426664
- J Korean Med Sci.
- 2018 Nov;33(48):e311.
- doi: 10.3346/jkms.2018.33.e311
BACKGROUND: In postmenopausal women, there is rapid bone loss due to estrogen depletion. In women, reproductive factors such as age at menarche, breastfeeding, and parity are considered risk factors of... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and Treatment of Osteoporosis
-
Oh YL
- KMID: 2329563
- J Reprod Endocrinol.
- 2012 Oct;4(2):99-106.
Osteoporosis is a silent disease until it is complicated by fractures-fractures that can occur following minimal trauma. Osteoporosis is common among older adults and results in costly osteoporotic fractures. With... -
- CITED
-
- Close
- SHARE
-
- Close
- The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period
-
Park SG, Jeong SU, Lee JH, Ryu SH, Jeong HJ, Sim YJ, Kim DK, Kim GC
- KMID: 2417836
- Ann Rehabil Med.
- 2018 Jun;42(3):441-448.
- doi: 10.5535/arm.2018.42.3.441
OBJECTIVE: To investigate appropriate treatment time and useful bone turnover markers (BTMs) for monitoring bone turnover during the postmenopausal period, we analyzed changes of two bone resorption markers; serum carboxyterminal... -
- CITED
-
- Close
- SHARE
-
- Close
